pharma · RSV Infection · NASH - Nonalcoholic Steatohepatitis · ENTA
ENANTA PHARMACEUTICALS
ENANTA PHARMACEUTICALS INC
Enanta Pharmaceuticals is a pharma organization headquartered in Watertown, USA. It trades on NYSE under ticker ENTA. Primary therapeutic focus areas include RSV Infection, NASH - Nonalcoholic Steatohepatitis, Non-Alcoho
4 Kingsbury Ave, Watertown, Massachusetts 02472, US HQ
1995 Founded
145 Employees
Public company Type
ENTA · NYSE Ticker
Company details
- Status
- Public
- HQ
- 4 Kingsbury Ave, Watertown, Massachusetts 02472, US
- Founded
- 1995
- Employees
- 145
- Programs
- 34
- Drugs
- 15
- Patents
- 218
EDP-305 1 mg
Phase 2 · small molecule · Primary Biliary Cholangitis
EDP-305 1 mg for Primary Biliary Cholangitis is a Phase 2 program (small_molecule) at ENANTA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Internal code EDP 305-201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- ENANTA PHARMACEUTICALS INC
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Primary Biliary Cholangitis
- Status
- completed
- Trials
- 1